IMCD N.V. completed the acquisition of Euro Chemo-Pharma Sdn. Bhd.
February 28, 2024
Share
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire Euro Chemo-Pharma Sdn. Bhd. on May 18, 2023. In this transaction, IMCD will also acquire Euro Chemo-Pharma's wholly owned subsidiary, Biofresh Green Sdn Bhd. Euro Chemo-Pharma has reported revenue of approximately MYR 270 million during financial year ended on June 30, 2022. The closing of the transaction is subject to customary closing conditions. The transaction is expected to take place in the last quarter of 2023.
IMCD N.V. (ENXTAM:IMCD) completed the acquisition of Euro Chemo-Pharma Sdn. Bhd. on February 29, 2024.
IMCD N.V. is one of the world's leaders in the distribution of specialty chemicals and food ingredients. The group's activity is organized primarily around 8 markets:
- house cleaning and maintenance products and textile products: surfactants, abrasives, bleaching agents, dyes, solubilizing agents, functional additives, etc.;
- pharmaceutical products: excipients, active pharmaceutical ingredients, solvents, formulation intermediates and chemical synthesis, etc.;
- personal care products: dyes, rheology modifiers, active and functional and sensory ingredients, sunscreen agents, antioxidants, exfoliants, preservatives, etc.;
- coating products: additives, pigments, resins and special solvents;
- nutritional and food products: acids, emulsifiers, oils, fibers, preservatives, sweeteners, enzymes, plant extracts, etc.;
- lubricants: additives, silicone derivatives, esters, corrosion inhibitors, markers, surfactants, etc.;
- chemical products synthesis: monomers, catalysts, reactive diluents, solvents and additives;
- plastic products: mixers, thermoplastic elastomers, polyurethanes, composite materials, etc.
Net sales break down geographically as follows: the Netherlands (1.5%), Europe/Middle East/Africa (42.2%), Asia/Pacific (24.5%), North America (22.3%), and Latin America (9.5%).